MBOT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Microbot Medical Inc

Watchlist Manager

Watchlist

Price: 1.44 USD -0.69% Market Closed

Market Cap: $96.7m

	Microbot Medical Inc NASDAQ:MBOT	US
	SPAR Group Ltd OTC:SGPPF	ZA
C	Constellation Brands Inc XMUN:CB1A	US

Profitability Summary

Microbot Medical Inc's profitability score is 13/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-185%

Negative 3Y Average Gross Margin

-92%

Negative Operating Margin

-5 349%

Negative 3Y Average Operating Margin

-10 313%

Negative Net Margin

-4 722%

Negative 3Y Average Net Margin

-9 129%

Negative Free Cash Flow Margin

-5 182%

Negative 3Y Average Free Cash Flow Margin

-9 915%

Negative ROE

-33%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1 473%

ROIC is Increasing

-1 354% > -728%

View All

Hide

Collapse

13 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.